NTHI

NeOnc Technologies Holdings Inc.

The biotech and pharma sector is entering one of its most pivotal periods in years, where insider conviction, late-stage clinical wins, and platform technologies are converging to reshape both valuations and patient outcomes. From aggressive insider buying ahead of critical data to blockbuster Phase 3 readouts redefining entire therapeutic categories, the market is signaling that the next cycle of winners may already be taking shape. $NTHI, $ERNA, $LLY, $NVO, $REGN, $MRNA

As market participants are sifting through data, one signal often cuts through the noise: insiders putting real money to work. Executives and strategic stakeholders have been accumulating shares in meaningful size, ranging from six-figure buys to billion-dollar commitments. While insider buying is never a guarantee of upside, it frequently reflects conviction rooted in operational visibility, upcoming catalysts, or perceived undervaluation. $NTHI, $RIVN, $SRAD, $NWBI, $FGBI

Biotech and pharma markets are leading the way in a sharply selective environment at midday, where clinical data, insider conviction, and platform scalability are driving outsized moves while weaker narratives get left behind. $NTHI, $POET, $SDOT, $BDRX, $CLRB, $DOCN, $FSLY, $EWTX, $BLDP

$CLRB, $NTHI, $BLZE, $DGXX, $VRDN, $CYTK are among today's leading stocks

NeOnc Technologies (NASDAQ:NTHI) is entering a high-stakes stretch and its CEO is making sure the market notices. In a series of open-market transactions, CEO and Executive Chairman Amir Heshmatpour has committed over $500,000 in recent weeks, bringing his total personal investment in the company to nearly $1 million over the past year. The timing is not subtle: it comes just as NeOnc approaches key clinical data readouts that could define its trajectory in the competitive field of brain cancer therapeutics.

A fresh insider signal just hit the tape for NeOnc Technologies Holdings (NASDAQ:NTHI), and it’s the kind of move traders tend to notice.

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour acquired 10,000 shares of the business's stock in a transaction on Thursday, April 23rd. The shares were...

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour acquired 10,000 shares of the firm's stock in a transaction dated Friday, April 10th. The shares were...

Neonc Technologies Holdings, Inc. (NASDAQ:NTHI - Get Free Report) President Amir Heshmatpour purchased 5,000 shares of the company's stock in a transaction on Thursday, April 9th. The shares were purchased at an average cost of $5.19 per share, with a total value of $25,950.00. Following the...